Erythroid cells and megakaryocytes are derived from a common precursor, the megakaryocyte-erythroid progenitor. Although these 2 closely related hematopoietic cell types share many transcription factors, there are several key differences in their regulatory networks that lead to differential gene expression downstream of the megakaryocyte-erythroid progenitor. With the advent of next-generation sequencing and our ability to precisely define transcription factor chromatin occupancy in vivo on a global scale, we are much closer to understanding how these 2 lineages are specified and in general how transcription factor complexes govern hematopoiesis. (Blood. 2011; 118(2):231-239)
IntroductionBecause of the relative accessibility of mature and progenitor cell types, their genetic tractability, and the availability of various functional assays, the hematopoietic system has long been used as a paradigm to study stem cells, lineage decisions, and gene regulation mediated by tissue-specific transcription factors. Both the relative and absolute levels of lineage transcription factors control fate decision and gene expression in specialized cell types. As hematopoietic cells differentiate from stem cells to the mature lineages, they gradually become more committed to their ultimate lineage, therein losing differentiation potential and gaining more specialized functionalities and differentiation focus. In the megakaryocyte and erythroid lineages, the final stage of noncommitted progenitor cell type is thought to be a common megakaryocyteerythroid progenitor (MEP). Progenitor cells, such as the MEP, are exceedingly rare and difficult to isolate because of their transient nature, although several lines of evidence support the existence of such a cell type in vivo. First, Debili et al identified a human CD34 ϩ CD38 low cell population that was capable of giving rise to colonies that contain both erythroid and megakaryocytic cells. 1 Second, in mice recovering from phenylhydrazine-induced anemia, a cell population expressing both erythroid and megakaryocytic markers can be isolated from spleens, and they form colonies containing both cell types. 2 Third, Akashi et al successfully isolated a CD34 Ϫ Fc␥R low fraction from mouse bone marrow that was capable of generating cells of either megakaryocytic or erythroid phenotype in single-cell differentiation experiments. 3 Finally, from Gata1 null murine fetal livers, Stachura et al isolated developmentally arrested cells which, when provided GATA-1, were capable of differentiating to both erythroid and megakaryocytic cells. 4 To completely understand the maturation program of megakaryocytes and erythrocytes (and the diseases that arise when differentiation goes awry), it is imperative that we define and characterize the transcription factors that specify and control the differences between the mature lineages as well as those that regulate their similarities and their common progenitor, the MEP.In the cells that compose the myeloid compartment of mammalian blood systems, transcripti...